We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Acoustic Device Designed to Separate Tumor Cells from Blood Cells Could Help Assess Cancer’s Spread

By LabMedica International staff writers
Posted on 23 Sep 2014
Researchers have devised a new way to separate cells by exposing them to sound waves as they flow through a tiny channel. More...
Their device, approximately the size of a dime, could be used to detect the extremely rare tumor cells that circulate in cancer patients’ blood, helping clinicians predict whether a tumor is going to metastasize.

Separating cells with sound offers a milder option to existing cell-sorting technologies, which require tagging the cells with chemicals or exposing them to stronger mechanical forces that may damage them. “Acoustic pressure is very mild and much smaller in terms of forces and disturbance to the cell. This is a most gentle way to separate cells, and there’s no artificial labeling necessary,” said Dr. Ming Dao, a lead research scientist in Massachusetts Institute of Technology’s (MIT; Cambridge, MA, USA) department of materials and engineering, and one of the senior authors of the paper, which was published in September 2014 in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Subra Suresh, president of Carnegie Mellon University (Pittsburgh, PA, USA), a professor of engineering emeritus, and a former dean of engineering at MIT, and Tony Jun Huang, a professor of engineering science and mechanics at Pennsylvania State University (Penn State; University Park, USA), are also senior authors of the article. The researchers have filed for a patent on the device; the technology of which they have demonstrated can be used to separate rare circulating cancer cells from white blood cells.

To sort cells using sound waves, scientists have previously built microfluidic devices with two acoustic transducers, which produce sound waves on either side of a microchannel. When the two waves meet, they combine to form a standing wave (a wave that remains in constant position). This wave generates a pressure node (line of low pressure) running parallel to the direction of cell flow. Cells that encounter this node are moved to the side of the channel; the distance of cell movement depends on their size and other properties such as compressibility.

However, these existing devices are inefficient: Because there is only one pressure node, cells can be pushed aside only short distances. The new device overcomes that obstacle by tilting the sound waves so they run across the microchannel at an angle: meaning that each cell encounters several pressure nodes as it flows through the channel. Each time it encounters a node, the pressure guides the cell a little further off center, making it simpler to capture cells of different sizes by the time they reach the end of the channel.

This simple modification drastically increases the efficiency of such devices, according to Taher Saif, a professor of mechanical science and engineering at the University of Illinois at Urbana-Champaign (USA). “That is just enough to make cells of different sizes and properties separate from each other without causing any damage or harm to them,” said Prof. Saif, who was not involved in this work.

In this study, the researchers first assessed the system with plastic beads, finding that it could separate beads with diameters of 9.9 and 7.3 micrometers with approximately 97% accuracy. They also devised a computer simulation that can predict a cell’s trajectory through the channel based on its size, density, and compressibility, as well as the angle of the sound waves, allowing them to tailor the device to separate different types of cells.

To evaluate whether the device could be useful for detecting circulating tumor cells, the researchers tried to separate breast cancer cells known as MCF-7 cells from white blood cells. These two cell types differ in size (20 micrometers in diameter for MCF-7 and 12 micrometers for white blood cells), as well as density and compressibility. The device successfully recovered about 71% of the cancer cells; the researchers plan to test it with blood samples from cancer patients to see how well it can detect circulating tumor cells in clinical settings. Such cells are very scarce; a 1-mL sample of blood may contain only a few tumor cells.

“If you can detect these rare circulating tumor cells, it’s a good way to study cancer biology and diagnose whether the primary cancer has moved to a new site to generate metastatic tumors,” Dr. Dao stated.

“This method is a step forward for detection of circulating tumor cells in the body. It has the potential to offer a safe and effective new tool for cancer researchers, clinicians, and patients,” Dr. Suresh concluded.

Related Links:

Massachusetts Institute of Technology
Carnegie Mellon University
Pennsylvania State University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health

Advances in molecular diagnostics are creating new opportunities to improve the detection of sexually transmitted infections, identify antibiotic resistance, and assess cancer recurrence risk in women.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.